News & Media

08/20/2015
Raymond A. Dionne D.D.S., Ph.D Joins Charleston Laboratories, Inc Scientific Advisory Board 
05/08/2014
Gary A. Peltz, M.D. Joins Charleston Laboratories, Inc Scientific Advisory Board 
05/02/2014
Charleston Laboratories, Inc. Announces Publication of Abstract for CL-108 Phase 3 Study at APS 2014 
03/22/2013
Charleston Laboratories, Inc submitted a request with the U.S. Food and Drug Administration (FDA) for a Pre-Investigational New Drug (Pre-IND) meeting regarding the development of CL-H1T. 
01/28/2013
Robert H. Dworkin, Ph.D Joins Charleston Laboratories, Inc Scientific Advisory Board 
01/07/2013
31st Annual J.P. Morgan Healthcare Conference 
12/01/2012
Charleston Laboratories, Inc. Appoints Ryan Baker Executive Vice President and Chief Operating Officer 
09/03/2012
Charleston Laboratories, Inc. Appoints Bill Kozarek Ph.D Vice President of Product Development 
01/09/2012
30th Annual J.P. Morgan Healthcare Conference 
05/18/2009
BIO International Convention 2009 
02/02/2009
Charleston Completes Preliminary Research on Nausea-Prone Questionnaire (NPQ) 
01/12/2009
Charleston Labs begins Bioequivalence Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of CL-108 
01/12/2009
27th Annual J.P. Morgan Healthcare Conference 
01/09/2009
Charleston Sucessfully Completes Series A Private Placement 
10/03/2008
Charleston Laboratories, Inc. Investigational New Drug CL-108 “Safe to Proceed Testing in Man.” 
01/07/2008
26th Annual J.P. Morgan Healthcare Conference 
08/01/2007
Charleston Laboratories, Inc. Appoints Bernard Schachtel, M.D. Chief Medical Officer 
08/01/2007
Charleston Laboratories, Inc. Appoints John F. Ameling V.P of Regulatory Affairs